Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:drugClass |
gptkb:Etoposide
Daunorubicin Doxorubicin Irinotecan Mitoxantrone Teniposide Topotecan |
| gptkbp:example |
gptkb:Etoposide
Daunorubicin Doxorubicin Irinotecan Mitoxantrone Teniposide Topotecan |
| https://www.w3.org/2000/01/rdf-schema#label |
Topoisomerase inhibitor
|
| gptkbp:mechanismOfAction |
Inhibits topoisomerase enzymes
|
| gptkbp:routeOfAdministration |
gptkb:Oral
Intravenous |
| gptkbp:sideEffect |
gptkb:Nausea
Diarrhea Hair loss Myelosuppression |
| gptkbp:subclassOf |
Antineoplastic agent
|
| gptkbp:target |
Topoisomerase I
Topoisomerase II |
| gptkbp:usedFor |
Cancer treatment
|
| gptkbp:bfsParent |
gptkb:Topoisomerase
|
| gptkbp:bfsLayer |
7
|